|
|
| | 1-BENZYL-1,2,3,4-TETRAHYDROISOQUINOLINE Basic information |
| Product Name: | 1-BENZYL-1,2,3,4-TETRAHYDROISOQUINOLINE | | Synonyms: | (RS)-1-benzyl-1,2,3,4-tetrahydroisoquinoline;1,2,3,4-tetrahydro-1-(phenylmethyl)isoquinoline;Isoquinoline, 1,2,3,4-tetrahydro-1-(phenylmethyl)- | | CAS: | 19716-56-4 | | MF: | C16H17N | | MW: | 223.31 | | EINECS: | | | Product Categories: | chem-chemical | | Mol File: | 19716-56-4.mol |  |
| | 1-BENZYL-1,2,3,4-TETRAHYDROISOQUINOLINE Chemical Properties |
| Boiling point | 120 °C(Press: 0.005 Torr) | | density | 1.060±0.06 g/cm3(Predicted) | | pka | 9.66±0.40(Predicted) |
| HazardClass | IRRITANT | | HS Code | 2933499090 |
| | 1-BENZYL-1,2,3,4-TETRAHYDROISOQUINOLINE Usage And Synthesis |
| Uses | 1-Benzyl-1,2,3,4-tetrahydro-isoquinoline is an endogenous metabolite present in Cerebrospinal_Fluid that can be used for the research of Parkinson's Disease[1][2]. | | Definition | ChEBI: (RS)-1-benzyl-1,2,3,4-tetrahydroisoquinoline is a benzyltetrahydroisoquinoline. It is a conjugate base of a 1-benzyl-1,2,3,4-tetrahydroisoquinolin-2-ium. | | References | [1] Lee N, et al. Endogenous toxic metabolites and implications in cancer therapy. Oncogene. 2020 Aug;39(35):5709-5720. DOI:10.1038/s41388-020-01395-9 [2] Kotake Y, et al. 1-Benzyl-1,2,3,4-tetrahydroisoquinoline as a parkinsonism-inducing agent: a novel endogenous amine in mouse brain and parkinsonian CSF. J Neurochem. 1995 Dec;65(6):2633-8. DOI:10.1046/j.1471-4159.1995.65062633.x |
| | 1-BENZYL-1,2,3,4-TETRAHYDROISOQUINOLINE Preparation Products And Raw materials |
|